Skip to content
Screener

Immunovant, Inc. IMVT United States — United States – State

Similar metrics at other companies

Reynolds Consumer Products Inc. logo
REYNUnited States — State
$2.75M-15.4%
Eagle Financial Services logo
EFSIOther States — Current State And Local Tax Expense Benefit
$14K+700%
KLX Energy Services Holdings, Inc. logo
KLXETexas — State
$125K-44.4%
Alset Inc. logo
AEIMaryland State — Current State And Local Tax Expense Benefit
$0-100%
Eagle Financial Services logo
EFSIMD — Current State And Local Tax Expense Benefit
$30.25K-4.7%
Energy Vault Holdings logo
NRGVUnited States — United States
-$20.73M+32.7%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$8.11B+197%
Enterprise value$7.21B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CurrentStateAndLocalTaxExpenseBenefit.

The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:28 AM EDT
Fiscal year
FY2026
Accession
0001764013-26-000064
Line itemYears Ended March 31, 2026Years Ended March 31, 2025Years Ended March 31, 2024
United Kingdom(55)
Total loss before income taxes$(505,391)$(412,949)$(258,769)
Current taxes
United States – Federal$880$562
United States – State215115
Total current tax expense215891567
Deferred tax expense
Total provision for income taxes$215$891$567

Item 8. Financial Statements and Supplementary Data

FAQ

What is Immunovant, Inc.'s united states — united states – state?
Immunovant, Inc. (IMVT) reported united states — united states – state of $53.75K in Q1 2026.
How has Immunovant, Inc.'s united states — united states – state changed year-over-year?
Immunovant, Inc.'s united states — united states – state increased by 1854.5% year-over-year, from $2.75K to $53.75K.
What is the long-term trend for Immunovant, Inc.'s united states — united states – state?
Over 4 years (2022 to 2026), Immunovant, Inc.'s united states — united states – state has grown at a 282.9% compound annual growth rate (CAGR), from $1K to $215K.
What does united states — united states – state mean?
Captures the income tax expense or benefit levied by individual U.S. state jurisdictions on the company's domestic segment operations. This metric reflects the localized tax burden imposed by state-level regulations. Monitoring this helps assess the geographic tax efficiency of the company's domestic footprint.

Ask your AI about Immunovant, Inc.'s united states — united states – state.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude